ACADIA Pharmaceuticals
ACAD
S$28.29
Share price
0.55%
Change (1 day)
16.81%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - Total debt
Total debt on the balance sheet as of March 2025 : S$71.99 Million
According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is S$71.99 Million. A company’s total debt is the sum of all current and non-current debts.
ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$70.67 M | -6.45% |
| 2023-12-31 | S$75.55 M | -9.1% |
| 2022-12-31 | S$83.11 M | -4.58% |
| 2021-12-31 | S$87.1 M | 32.89% |
| 2020-12-31 | S$65.54 M | 396.37% |
| 2019-12-31 | S$13.2 M | |
| 2018-12-31 | N/A | |
| 2011-12-31 | S$0.04 M | -70.75% |
| 2010-12-31 | S$0.14 M | -78.2% |
| 2009-12-31 | S$0.65 M | -62.9% |
| 2008-12-31 | S$1.75 M | -42.95% |
| 2007-12-31 | S$3.07 M | -15.68% |
| 2006-12-31 | S$3.64 M | 22.74% |
| 2005-12-31 | S$2.96 M | -28.11% |
| 2004-12-31 | S$4.12 M | -50.08% |
| 2003-12-31 | S$8.26 M | -25.94% |
| 2002-12-31 | S$11.16 M | 355.83% |
| 2001-12-31 | S$2.44 M | -75.59% |
| 2000-12-31 | S$10.03 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Vanda Pharmaceuticals VNDA | S$15.09 M | -79.03% | 🇺🇸 USA |
 Pfizer PFE | S$78.79 B | 109,336.49% | 🇺🇸 USA |
 Eli Lilly LLY | S$49.51 B | 68,671.02% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$67.17 B | 93,197.15% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$65.86 B | 91,388.41% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | N/A | N/A | 🇺🇸 USA |